Chronic cerebral hypoperfusion induces post-stroke dementia following acute ischemic stroke in rats
نویسندگان
چکیده
منابع مشابه
dysphagia in acute ischemic stroke
Introduction: Swallowing dysfunction complicates acute strokes in 25-32% of cases and directly affects patientschr('39') prognosis and recovery. Dysphagia complicates the course of acute strokes through its potential of the development of chest infection, nutritional problems, and dehydration. Dysphagia is also an independent predictor of respiratory morbidity and mortality in acute stroke. In...
متن کاملO10: Thrombo-Inflammation in Acute Ischemic Stroke
Ischemic stroke has been classified as a merely thrombotic disease, so the main goal of its treatment is the recanalization of the occluded vasculature. However, despite fast restoration of blood circulation, progressive stroke still develops in many patients, which has led to the concept of reperfusion injury. The underlying mechanism is only partly known. Though, it is accepted now, tha...
متن کاملPost stroke dementia and Post stroke depression
Stroke is the rapid loss of brain function due to disturbance in the blood supply to the brain causing predominantly motor and sensory symptoms. However, stroke can cause some other symptoms. Post stroke dementia and depression are probably the most important non-motor consequences of stroke. Post stroke dementia and depression are important and often overlooked symptoms following stroke. Treat...
متن کاملBacterial pneumonia following acute ischemic stroke.
BACKGROUND The most common serious complication following acute ischemic stroke is pneumonia, which may increase mortality and worsen clinical outcomes. The purpose of this study was to investigate the predictors of 30-day mortality in patients with pneumonia following acute ischemic stroke. METHODS From June 2006 to May 2011, we retrospectively included 51 patients with pneumonia following a...
متن کاملOptimal platelet inhibition following acute ischemic stroke.
hibitor following stroke, nor do we know the appropriate loading regimen or dosage interval to maximize platelet inhibition and patient outcome. The same problem exists with platelet inhibition for secondary stroke prevention following TIA. The Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial, comparing clopidogrel (600 mg load followed by 75 mg daily) with aspiri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neuroinflammation
سال: 2017
ISSN: 1742-2094
DOI: 10.1186/s12974-017-0992-5